Join Growin Stock Community!

啟新生7837.TW Overview

TW StockBiotech. & Medical
(No presentation for 7837)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

啟新生（7837）Overall Performance

啟新生（7837）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

啟新生（7837） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

啟新生（7837）Key Information

啟新生（7837）Profile

啟新生（7837）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

7837

啟新生

112.50D

-2.22%

(-0.02)

  • When is 7837's latest earnings report released?

    The most recent financial report for 啟新生 (7837) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7837's short-term business performance and financial health. For the latest updates on 7837's earnings releases, visit this page regularly.

  • How much cash does 7837 have?

    At the end of the period, 啟新生 (7837) held Total Cash and Cash Equivalents of 249.86M, accounting for 0.19 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7837 go with three margins increasing?

    In the latest report, 啟新生 (7837) achieved the “three margins increasing” benchmark, with a gross margin of 39.24%%, operating margin of 10.25%%, and net margin of 9.41%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7837's profit trajectory and future growth potential.